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ABSTRACT: Introduction: SARS-CoV-2 is a new coronavirus, 
responsible for the current pandemic of COVID-19, which has 
already infected and caused the death of thousands of people 
around the world. Objective: To describe basic and fundamental 
aspects of SARS-CoV-2, such as its name, constitution, possible 
origins and classification. Method: Exploratory and descriptive 
bibliographic review, elaborated through researches on the 
Pubmed, Scopus, Google Scholar, and Scielo platforms. The 
terms used for the selection of materials were “SARS-CoV-2” 
“COVID-19”, “spike-protein”, “classification”, “coronavirus” 
and their combinations. Results: Coronaviruses belong to 
the Coronaviridae family, which comprises two subfamilies, 
five genera, 26 subgenera and 46 virus species. SARS-CoV-2 
belongs to the genus Betacoronavirus, subgenus Sarbecovirus, 
a coronavirus species related to the acute respiratory syndrome. 
Its classification, carried out by the International Committee on 
Taxonomy of Viruses (ICTV)], was made in the light of mainly 
molecular and phylogenetic characteristics and not the actual 
disease it causes. This virus appeared in China, where people 
have the habit of consuming recently slaughtered domestic or 
wild animals. It is speculated that the horseshoe bat (Rhinolophus 
sinicus) is its primary host and that the Malayan pangolin (Manis 
javanica) is the secondary host. SARS-CoV-2 is an enveloped 
virus, approximately spherical and its virions have average 
diameters of 80-120 nm. It has a non-segmented RNA large size 
genome which encodes four main proteins spike (S), envelope 
(E), membrane (M) and nucleoprotein (N). Coronaviruses use 
S as the main target to neutralize antibodies and to bind to 
the angiotensin-converting enzyme 2. Conclusion: In-depth 
knowledge of the basic characteristics of SARS-CoV-2 is essential 
for better comprehension and understanding of epidemiological 
aspects, clinical, pathophysiological and treatment of COVID-19.
Keywords: SARS-CoV-2. Coronavirus. Classification. Viral 
structure. Origin.
RESUMO: Introdução: O SARS-CoV-2 é um novo coronavírus, 
responsável pela atual pandemia de COVID-19, o qual já infectou e 
causou a morte de milhares de pessoas em todo o mundo. Objetivo: 
Descrever aspectos básicos e fundamentais sobre o SARS-CoV-2, 
como nome, constituição, possíveis origens e classificação. 
Método: Revisão bibliográfica exploratória e descritiva, elaborada 
por meio de pesquisas nas plataformas PubMed, Scopus, Google 
Acadêmico, e SciELO. Os termos utilizados para a seleção dos 
materiais foram: “SARS-CoV-2”, “COVID-19”, “spike-protein”, 
“classification”, “coronavirus” e suas combinações. Resultados: 
Os coronavírus pertencem à família Coronaviridae, a qual abrange 
2 subfamílias, 5 gêneros, 26 subgêneros e 46 espécies de vírus. 
O SARS-CoV-2 pertence ao gênero Betacoronavirus, subgênero 
Sarbecovirus, espécie Severe acute respiratory syndrome-related 
coronavirus, e está relacionado à síndrome respiratória aguda. 
Sua classificação foi realizada pelo International Committee 
on Taxonomy of Viruses (ICTV) levando-se em consideração 
principalmente características moleculares e filogenéticas e 
não a doença que causa. Este vírus surgiu na China, país em 
que há o hábito de consumir animais domésticos ou selvagens 
recentemente abatidos. Especula-se que o morcego-ferradura 
(Rhinolophus sinicus) seja o seu hospedeiro primário e que o 
pangolim malaio (Manis javanica) o hospedeiro intermediário. O 
SARS-CoV-2 é um vírus envelopado, aproximadamente esférico, 
e os seus vírions têm diâmetros médios de 80 a 120 nm. Possui 
genoma de RNA não segmentado, fita simples, codificando 
quatro proteínas principais: glicoproteína espicular (S), proteína 
do envelope (E), glicoproteína da membrana (M) e proteína do 
nucleocapsídeo (N). Os coronavírus utilizam a S como principal 
alvo para neutralizar anticorpos e para se ligar ao receptor enzima 
conversora de angiotensina 2. Conclusão: O conhecimento 
aprofundado sobre as características básicas do SARS-CoV-2 
é fundamental para a melhor compreensão e entendimento dos 
aspectos epidemiológicos, clínicos, fisiopatológicos e para o 
tratamento da COVID-19.
Descritores: SARS-CoV-2; Coronavirus; Classificação; Estrutura 
viral; Origem.
474
Khalil OAK, Khalil SS. SARS-CoV-2: taxonomy, origin and constitution
INTRODUCTION
Viruses and viral diseases have been at the centers of science, agriculture, and medicine 
for millennia and some of our greatest challenges and 
triumphs have involved virology1.
Infectious diseases afflict humanity since the 
beginning of civilization. The concern must be focused on 
the future and not on the past2, however, the COVID-19 
outbreak, caused by the zoonotic virus SARS-CoV-2 is, 
presently, the greatest global apprehension and one never 
seen before in the history of humanity. 
Zoonoses are the diseases and infections that are 
naturally transmitted between vertebrate animals and 
humans, caused by exposure between them, and are 
usually limited to agents that can replicate in the animal 
host. This definition is valid even when the agent has the 
ability to, afterwards, spread within human populations 
without any animal exposure, as exemplified for the severe 
acute respiratory syndrome (SARS) coronavirus, MERS 
(Middle Eastern Respiratory Syndrome) coronavirus3, and 
SARS-CoV-2.
A significant number of the diseases currently 
affecting humans originated in sylvatic cycles, and have 
crossed over at one point or the other due to the ability 
of viruses to mutate rapidly and adapt to new species, 
especially in the case of RNA viruses. In zoonosis diseases, 
a spatial and physical association of feral and domesticated 
species creates the setting for viruses to cross the species 
barrier, resulting in emergent diseases. Humans have played 
a major part in such emerging zoonosis throughout the 
centuries, with activities such as farming, deforestation, and 
urbanization4. The study of how zoonotic viruses become 
human pathogens has already become a major focus of 
21st century virology1.
The 2003 outbreak of severe acute respiratory 
syndrome (SARS), a disease caused by a coronavirus 
identified as a etiological agent of severe acute respiratory 
syndrome, shocked the world as it spread swiftly from 
continent to continent, resulting in >8,000 infections, with 
approximately 10% mortality, and a devastating effect on 
local and regional economies, becoming the first pandemic 
of the 21st century5. Whereas COVID-19, declared a 
pandemic on March 11th of 2020 by the World Health 
Organization6, accounted for about 100.000 deaths after 
the announcement of this institution7. In fact, Covid-19 
has already caused 10 times as many cases as SARS in a 
quarter of the time8.
The coronaviruses (CoVs) already identified might 
only be the tip of the iceberg, with potentially more novel 
and severe zoonotic events to be revealed9.
Even in the academic environment, there is still 
great difficulty to comprehend the basic aspects related 
to SARS-CoV-2, since the scientific production related 
to this virus is recent and predominantly in a foreign 
language. Therefore, the objective of this article is to deal 
with the basic aspects related to the virus, such as its name, 
taxonomy, origin, and constitution.
METHOD
This is an exploratory and narrative review of basic 
aspects of SARS-CoV-2. The research was carried out in 
the Pubmed, Scopus, Google Scholar, and Scielo electronic 
databases, with a focus on obtaining and analyzing 
articles published in 2019 and 2020. The Health Sciences 
Descriptors (either alone or combined) used were: “SARS-
CoV-2” along with terms “COVID-19”, “spike-protein”, 
“classification”, “coronavirus”. The terms were defined by 
the Medical Subject Headings (MeSH).
The materials were between April 1, 2020, and April 
30, 2020. Original and review studies were obtained and 
analyzed, mainly in English, Spanish, and Portuguese in 
which the title, abstract, and topics were aligned with the 
terms of interest. The contents of interest were described 
according to their relevance in contributing to the objective 
of this study.
Origin: China
The two major outbreaks of infectious diseases 
caused by bat CoVs (SARS and COVID-19) emerged in 
China. The factors that contributed to the emergence of 
these diseases in this country were: (1) the vast homeland 
plus diverse climates that bring about a great biodiversity 
including that of bats and bat-borne viruses— the majority 
of CoVs can be found in China and more than 50% of 
the identified species (22/38) were named by Chinese 
scientists studying local bats or other mammals; (2) most 
of the bat hosts of these CoVs live near humans, potentially 
transmitting viruses to humans and livestock; (3) Chinese 
food culture maintains that live slaughtered animals 
are more nutritious, and this belief may enhance viral 
transmission10. This last factor had already been pointed 
out more than a decade ago as a strong alert: the presence 
of a large reservoir of SARS-CoV-like viruses in horseshoe 
bats, together with the culture of eating exotic mammals 
in southern China, is a time bomb for the possibility of 
the re-emergence of SARS and other novel viruses from 
animals or laboratories11.
Origin: horseshoe bat (Rhinolophus sinicus)
Overflow is the term derived from “Spillover” 
(“Host Transfer” or “Host switching”), which designates 
the process in which the passage of naturally infecting 
pathogen agent of an infected animal population occurs 
to a host species previously not affected by this agent, 
such as the human species. The persistence or not of the 
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infection, whether in an endemic or epidemic manner, will 
depend on the easiness for the inter-human transmission of 
the emerging pathogen to occur, greatly determined by the 
genetic and physiological characteristics of the emerging 
pathogen and the new host12.
Coronaviruses (CoVs) are zoonotic viruses with 
the ability to infect a diversity of animals (domestic or 
not) and humans. These nonspecific properties that CoVs 
possess may be due to accessory CoV genes, which are 
already thought to play a role in host tropism and adaptation 
to a new host. S-Glycoprotein appears to be the main 
determinant for the success of initial events of infection 
between species13, while the angiotensin-converting 
enzyme 2 (ACE2) is known as a human receptor for this 
viral spike surface glycoprotein, which facilitates its 
transmission between species14.
Among animals, it is evident that bats are the group 
of mammals that harbor the largest number of CoVs and 
that many other animal CoVs recognize their ancestors in 
bat CoVs15.
Domestic animals may have important roles as 
intermediate hosts that enable virus transmission from 
natural hosts to humans. In relation to SARS-CoV, it is 
suggested that bats may be the natural hosts for SARS-CoV 
and that civets (Paguma larvata) were only intermediate 
hosts, whereas, for MERS-Cov, the dromedary camels 
were only intermediate hosts16. In both of these epidemics, 
these viruses have likely originated from horseshoe bats 
(Rhinolophus sinicus) and then jumped into another 
amplification mammalian host, the Himalayan palm civet 
(Paguma larvata) for SARS-CoV and the dromedary 
camel (Camelus dromedarius) for MERS-CoV before 
crossing species barriers to infect humans. Based on the 339 
complete SARS-related coronavirus genomes analysis, it is 
suggested that the SARS-CoV-2 might also have originated 
from bats, however, it is not possible to determine whether 
another intermediate or amplification animal host infected 
by this virus would be related to COVID-1917.
It is possible that SARS-CoV-2 entered human 
populations through intermediate host(s). However, few 
SARS-CoV-2-related viruses have been described in 
mammals other than bats and humans.
The SARS-CoV-2-related viruses are still poorly 
sampled in mammals (even in bats) to reach a conclusion. 
The identification of two distinct viral clusters in pangolins 
indicates that SARS-CoV-2-related virus might be more 
widely distributed in wild mammals than expected18. 
The high similarity between the Guangdong 
pangolin CoVs and SARS-CoV-2 in the RBD raises 
concern that these viruses might be readily transmitted to 
human populations. More work is necessary to explore 
the pathogenicity and diversity of CoVs in pangolins. 
Nevertheless, due to their status of being endangered, and 
the risk of causing future CoV outbreaks, the hunting, 
handling, and trafficking of pangolins should be strictly 
prohibited. Further surveillance of SARS-CoV-2-related 
viruses in mammals might help to clarify the origin of 
SARS-CoV-218.
There is evidence to point to the Malayan pangolin 
(Manis javanica) as the probable origin of SARS-CoV-2, 
responsible for the outbreak of COVID-19. Through the 
analysis from lung samples of two dead Malayan pangolins 
with a frothy liquid in their lungs and pulmonary fibrosis 
discovered close to when the COVID-19 outbreak occurred, 
a Pangolin-CoV was identified, with a potential kinship 
of SARS-CoV-2 (91.02% genomic similarity and 90.55% 
genomic similarity with BatCoV RATG13, a Cov of bats), 
being the coronavirus most closely related to SARS-
CoV-2 already described. Considering the widespread of 
SARSr-CoVs in natural reservoirs, such as bats, camels, 
and pangolins, these findings are significant for attempts 
to block interspecies viral transmission19.
The close phylogenetic relationship to BatCoV 
RaTG13 provides evidence that SARS-CoV-2 may have 
originated in bats20. This way, similar to what happened 
in 200221, civets can be the intermediate hosts for the 
transmission of SARS-CoV to humans.
Virus name
The naming of a new virus is important not only 
for the virologists in long-term, but also for efficient 
communication to the public in general. In all the major 
emerging zoonotic viruses events over the past 25 years, 
the naming of the new virus has not been straightforward 
and most went through a renaming process22.
The name of the virus is not necessarily connected 
to a disease, but to its characteristics, such as its phylogeny. 
There is a vast quantity of viruses with phenotypic 
characteristics that are not known, which makes the 
sequences of its genomes the only precise characteristic 
known for the great majority of virus [viruses] and 
that can be used to define specific ones. Based on this, 
Coronaviridae Study Group (CSG) of the International 
Committee of Taxonomy of Viruses (ICTV), responsible for 
the classification of viruses and the naming of taxa of the 
Coronaviridae family, designated the virus responsible for 
the outbreak of the COVID-19 diseases as SARS-CoV-223.
The term “corona” derives from the structural 
glycoprotein’s organization around the virus, which 
resembles a crown13.
Although the CGS claimed that they did not intend 
to make any reference to SARS disease, it is pointed 
out that the name of the virus as SARS-CoV-2 was not 
adequate, because SARS is a disease name, and to name 
the new virus SARS-CoV-2 actually implies that it causes 
SARS or similar, especially to scientists without much 
knowledge of virology and to citizens in the public domain. 
Furthermore, the new virus name is also not consistent 
with the disease name COVID-19. On the basis of special 
476
Khalil OAK, Khalil SS. SARS-CoV-2: taxonomy, origin and constitution
clinical, virological, and epidemiological characteristics 
and the uncertainty of the novel coronavirus, to avoid the 
misleadingness and confusion, and to help scientists and 
the public with better communication, a group of virologists 
in China, suggest renaming SARS-CoV-2 as human 
coronavirus 2019 (HCoV-19). Such a name distinguishes 
the virus from SARS-CoV and keeps it consistent with the 
WHO name of the disease it causes, COVID-1924. On the 
other hand, it is still possible to find the designation 2019-
nCoV as a descriptor of this virus25.
The WHO does not recommend the usage of the 
term SARS for the outbreak caused by the new coronavirus 
in 2020. Instead, in order to avoid unnecessary fear in some 
populations, especially in Asia, which was the most affected 
by the SARS outbreak in 200326, it is more appropriate to 
name it COVID-19.
Regarding the name of the disease, COVID-19 
(short for “coronavirus disease 2019”) is the term of a viral 
disease that followed WHO best practices for the naming of 
new human infectious diseases, which were developed in 
consultation and collaboration with the World Organization 
for Animal Health (OIE) and the Food and Agriculture 
Organization of the United Nations (FAO)27.
Virus taxonomy
To ignore the adequate taxonomy is to ignore 
history; it is also to ignore the similarities and differences 
between living beings, as well as the evolutionist ideas of 
classification28.
Phylogenetically, Coronaviridae belongs to 
Nidovirales in group IV, with a single genomic RNA 
fragment, oriented in a positive direction13 and comprises 
two subfamilies, five genera, 26 subgenera, and 46 virus 
species29.
SARSr-CoVs belong to the subgenus Sarbecovirus 
(previously lineage B) of genus Betacoronavirus and 
occupy a unique phylogenetic position. SARS-CoV-2 is the 
name of the virus that belongs to the coronavirus species 
related to the acute respiratory syndrome, abbreviated as 
SARS-rCoV29. The seventh human coronavirus, SARS-
CoV-2, belongs to the genus Betacoronavirus, which 
also contains SARS-CoV and MERS-CoV30. Figure 1 
demonstrates the taxonomy of this virus.
Source: prepared by the authors (2020).
Figure 1. Taxonomy of SARS-CoV-2
The CoVs of the α and β genera generally infect 
mammals and humans, while the CoVs of the γ and δ 
genera mainly infect birds, but some of them can also 
infect mammals31.
The amino acid sequences of the seven conserved 
replicase domains in ORF1ab that were used for CoV 
species classification were 94.4% identical between SARS-
CoV-2 and SARS-CoV, suggesting that the two viruses 
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belong to the same species, SARSr-CoV20.
Phylogenetic studies on SARS-CoV-2 genomic 
sequences revealed that it clustered closely with sequences 
originating from SARS-like sequences from bats, within 
lineage B of the Betacoronavirus genus. HCoV-HKU1 
and HCoV-OC43 are grouped in lineage A. MERS-CoV is 
found within lineage C, along with related camel derived 
MERS-CoV. Lineage C also groups viruses from bats and 
other mammals such as hedgehogs. Lineage D contains 
viral species infecting bats32.
SARS-CoV-2 constitution
Coronaviruses are roughly spherical and moderately 
pleomorphic and enveloped viruses. Virions have typically 
been reported to have average diameters of 80–120 
nm33. The CoVs have a positive-sense, non-segmented, 
single-stranded RNA, 5’-capped, 3’-polyadenylated, and 
astoundingly large size ranging from 27 to 32 kilobases34.
The virus genome consists of six major open-
reading frames (ORFs) that are common to coronaviruses 
and several other accessory genes20. CoVs are characterized 
by the property of transcribing code mRNAs for each 
protein. This property allows the virus to control the rate 
of protein synthesis according to its state requirements and 
that of the host cell13. The coronavirus replication cycle is 
divided into several steps: attachment and entry, translation 
of viral replicase, genome transcription and replication, 
translation of structural proteins, and virion assembly and 
release34.
CoVs encode membrane-associated proteins that 
are incorporated into virions: spike (S), envelope (E), 
membrane (M), and nucleoprotein (N)13. Virus infectivity 
studies using HeLa cells that expressed or did not express 
ACE2 proteins from humans were conducted to determine 
whether SARS-CoV-2 also uses ACE2 as a cellular entry 
receptor. Chinese horseshoe bats, civets, pigs, and mice] 
SARS-CoV-2 is able to use all ACE2 proteins, but not 
with aminopeptidase N (APN) and dipeptidyl peptidase 4 
(DPP4), indicating that ACE2 is probably the cell receptor 
through which 2019-nCoV enters cells20.
CoV uses its spike glycoprotein (S), the main 
target for neutralization antibody, to bind its receptor, and 
mediate membrane fusion and virus entry. The S protein 
contains two subunits, S1 and S2, mediating attachment 
and membrane fusion, respectively35. 
The type I glycoprotein S protrudes from the surface 
of the virus and attracted great attention because of its 
function in receptor binding cell36. S-glycoprotein appears 
to be the main determinant for the success of initial events 
of infection between species13.
Understanding the main structural and molecular 
components of SARS-CoV-2 is a fundamental way 
to reach COVID-19 therapy. As there is currently no 
pharmacological treatment available for this disease and 
due to its severity, there is an urgent need to find therapeutic 
options in support of the current protocols to assist in the 
prevention, treatment, control of symptomatology, and 
decrease the severity of SARS-CoV infections37. Although 
vaccines under development are in advanced clinical stages, 
currently there are no licensed vaccines for any coronavirus 
yet. Despite efforts in fast-tracking vaccine development, 
completion dates for early clinical trials are estimated to be 
late 2020 to mid-2021 and it may still take longer before a 
vaccine is licensed for use globally, which emphasizes the 
need for proven public health strategies such as physical 
distancing, early detection, and self-isolation as important 
mitigation tools38.
CONCLUSION
The new coronavirus SARS-CoV-2 is the etiological 
agent of COVID-19, a highly infectious disease that affects 
mainly the lower respiratory tract which the first cases 
were reported in China in 2019. Since then, the virus has 
spread all over the world, causing a pandemic that results in 
catastrophic consequences for global health and economy: 
besides the millions of deaths and permanent sequels in 
many survivors, it created or aggravated an economic crisis, 
especially in developing countries like Brazil.
Although there were initial discussions related to its 
name, ICTV officially designated it as SARS-CoV-2 and the 
WHO designated the name of the diseases as COVID-19. 
Both took into consideration technical and even ethical 
aspects, avoiding to stigmatize and deepen the prejudice 
and xenophobia that surround this theme. 
Because it is a zoonotic virus with a spillover that 
is related to the horseshoe bat as a primary host and as 
a possible domesticated or commercialized secondary 
host for human food, SARS-CoV-2 raises the permanent 
challenge related to the human-animal relation, whose 
analysis of its interactions should predominate on the 
individual perspectives of one another if we wish to settle 
or avoid the emergence of new viral lineages or species 
in humans.
Finally, in-depth knowledge about the receptors 
and its targets an the basis of viral replication would be a 
great step forward to find a remedy for the SARS-CoV-2 
infection39.
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